Epidemiology of cervical cancer in Latin America

Capote Negrin, Luis G.
December 2015
Ecancermedicalscience;2015, Vol. 9 Issue 577-607, p1
Academic Journal
The basic aspects of the descriptive epidemiology of cervical cancer in Latin America are presented. A decrease in the incidence and mortality rates has been observed in the period from 2000 to 2012 in all countries across the region, this has not occurred at the same proportions, and in many countries, observed figures of incidence and mortality are among the highest levels in the world. In Latin America, calculating a mean measure of the numbers from the GLOBOCAN data from 2000 to 2012, we can observe a difference of up to fivefold of the incidence (Puerto Rico 9,73 Vs Bolivia 50,73) and almost seven times for mortality (Puerto Rico 3,3 Vs Nicaragua 21,67). A report of the epidemiology, risk factors, and evaluation of screening procedures regarding the possible impact of the human papillomavirus (HPV) vaccine I in the prevention of cervical cancer is presented.


Related Articles

  • Appendix 1: Model protocol for the manufacturing and control of recombinant human papillomavirus virus-like particle vaccines.  // WHO Technical Report Series;2016, Issue 999, p216 

    An appendix is presented of model protocol for manufacturing and control of recombinant human papillomavirus virus-like particle vaccines from the World Health Organization.

  • Help teens, parents see value of HPV vaccine. Gold, Melanie; Duffy, Kaityi // Contraceptive Technology Update;Jul2009, Vol. 30 Issue 7, p81 

    The article presents the findings of a study published in the Journal of the National Cancer Institute investigating the Human papillomavirus (HPV) genotyping of cases in invasive cervical cancer in women from New Mexico.

  • Effect of educational brochures on Cherokee women with... Pardini, Ricci S. // Public Health Reports;Nov/Dec96, Vol. 111 Issue 6, p546 

    Studies on the increase incidence of cervical cancer among Cherokee women and its impact on health care researchers and providers. Early detection and treatment of cervical cancer and its implications; Focus of the North Carolina Native American Cervical Cancer Prevention Project (NCP);...

  • Appendix 2: Model NRA Lot Release Certificate for recombinant human papillomavirus virus-like particle vaccines.  // WHO Technical Report Series;2016, Issue 999, p232 

    An appendix is presented of model NRA Lot Release Certificate for recombinant human papillomavirus virus-like particle vaccines from the World Health Organization Expert Committee on Biological Standardization.

  • About this issue …. Dreyer, Greta // Southern African Journal of Gynaecological Oncology;2011, Vol. 3 Issue 2, p52 

    An introduction is presented in which the editor discusses various reports within the issue on topics including the important components of supportive care, research on studies on cervical cancer, and cervical cancer awareness.

  • Simplified GOG risk criteria validated in stage IB cervical cancers.  // Hem/Onc Today;4/25/2010, Vol. 11 Issue 8, p47 

    The article focuses on a research by Dr. Hee-Sug Ryu of the Ajou University Hospital about the risk criteria of the Gynecologic Oncology Group (GOG) for treatment of patients with stage IB cervical cancers after radical hysterectomy presented at The Society for Gynecologic Oncologists' 2010...

  • Concurrent chemoradiation for cervical carcinoma led to more toxicity. Cona, Christen // Hem/Onc Today;11/25/2010, Vol. 11 Issue 22, p16 

    The article focuses on a study which revealed that holding concurrent chemoradiation for patients cervical carcinoma caused higher incidence of hematological and gastrointestinal toxicities.

  • Training in the prevention of cervical cancer: advantages of e-learning. Company, Assumpta; Montserrat, Mireia; Bosch, Francesc X.; de Sanjosé, Silvia // Ecancermedicalscience;2015, Vol. 9 Issue 577-607, p1 

    Cervical cancer remains the second most common cancer for women worldwide and is the cancer priority in most low- and middle-income countries (LMIC). The development of vaccines against the human papilloma virus (HPV) and the impact of technology both for the detection of HPV and cervical cancer...

  • New Study: Cervical Cancer Lingers in Black Women. Vance, Felicia // Tennessee Tribune;5/3/2012, Vol. 23 Issue 19, p3B 

    The article discusses a study conducted on black women to depict that black women are more prone to cervical cancer than whites, and reflects that black women's immune system finds it difficult to fight against Human Papilloma Virus (HPV), the virus that causes the disease.

  • Choice of cancer vaccine is branded a missed opportunity by charities. Kmietowicz, Zosia // BMJ: British Medical Journal (International Edition);6/28/2008, Vol. 336 Issue 7659, p1456 

    The article discusses how health charities are criticizing the adoption of the drug Cervarix into national immunisation initiatives in Great Britain. Cervarix, developed by the pharmaceutical firm GlaxoSmithKline is designed to vaccinate women against human papillomaviruses, which can cause...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics